NASDAQ · ECXWW
ECARX Holdings Inc. Warrants financials
$0.0218−5.63%
Close Sep 23, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Gross margin | — | — | — |
| Operating income | — | — | — |
| Net income | — | — | — |
| Net margin | — | — | — |
| Diluted EPS | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — |
| Free cash flow | — | — | — |
| Diluted shares | 338.7M | 336.6M | 337.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $87.1M | $44.3M | $80.8M |
| Short-term investments | $31.2M | $17.9M | $19.5M |
| Total debt | $415.3M | $249.7M | $235.3M |
| Total assets | $662.4M | $514.3M | $608.5M |
| Total liabilities | $945.9M | $752.0M | $726.0M |
| Shareholders' equity | -$283.5M | -$237.7M | -$117.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology